Testosterone Management in Aging Males: Surveying Clinical Practices of Urologists and Endocrinologists in Israel

Abstract

Introduction: Although there is increased public concern about low testosterone levels in aging men, the diagnosis and treatment of hypogonadism in this growing population is controversial. Aim: To document the current practices of endocrinologists and urologists in the management of older men with low testosterone in Israel. Methods: A 20-question survey of the management of hypogonadism was sent to members of the Israel Endocrine Society and the Israeli Urology Association Main Outcome Measures: Participants were interviewed about their practice in diagnostic workup, prescription habits and monitoring of testosterone therapy. Results: The response rate was low (range 8e12%). Significant differences were found between members of the 2 professional associations. Overall, endocrinologists take a more conservative approach to the diagnosis and initial workup, modes of treatment, and to concerns about the safety of testosterone therapy. A divergence from the published clinical guidelines was also noted in some aspects of the clinical practices in both groups. Clinical Implications: Significant variances in the diagnosis and treatment approach of hypogonadism between endocrinologists and urologists, as well as divergences from clinical guidelines, may lead to misuse of testosterone therapy. Strengths & Limitations: This is the first study undertaken in Israel among urologists and endocrinologists of this increasingly recognized health issue. In our country, these 2 groups of physicians comprise nearly all of the testosterone treatment providers. The limitation of this study is linked to bias of all surveys based on subjective reporting, the fact that it was performed in only 1 country, and that we did not control for the specific assay used to measure testosterone levels. Conclusions: These findings highlight the need for the implementation of coordinated guidelines to facilitate the appropriate diagnosis and treatment of men who can benefit from testosterone therapy and to minimize the risks of this therapy. Ishay A, Tzemah S, Nitzan R, et al.

Testosterone prescribing in UK general practice: Are patients being monitored correctly for associated risks whilst on treatment?

“…The prescribing and monitoring of testosterone replacement therapy may be under the control of a variety of speciality teams who vary in how closely they supervise any safety concerns. In one recent study 1 in Israel, for example, where such monitoring is performed by endocrinologists or urologists, the latter were found to be “more conservative” in their approach.…”

Caloric restriction-mimetics for the reduction of heart failure risk in aging heart: with consideration of gender-related differences

“…This notion, however, needs further evidence to corroborate. As an important androgen in males, circulating testosterone concentrations decline as men age [ 117 ]. Testosterone replacement strategy can mitigate some of the aging characteristics, but it does not significantly improve physical function in aged men [ 118 , 119 ].…”

An Updated Review: Androgens and Cognitive Impairment in Older Men

“…Human aging is an inevitable process (1). As aging occurs, the gonads decrease in function, and there is a decrease in the levels of sex hormones (2). The most important sex hormones in men are androgens, which are involved in maintaining the normal functions of multiple tissues and organs in human physiology (3).…”